Syensqo Ventures
VC Fund
Brussels, Belgium
Syensqo Ventures is a VC fund in Brussels focused on Manufacturing and Chemical. Solvay Ventures is the Venture Capital arm of Solvay through a 100 millions $ evergreen fund.
- Total investments:
- 25
- Last investment:
- Lead investor:
- 24%
Last updated:
For AI agents: llms.txt
Industries Syensqo Ventures invests in
Stages Syensqo Ventures invests in
Countries Syensqo Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $2.1M–$23M
- Series A
- $6M–$28M
- Series B
- $1.6M–$52M
Investment Focus
Industry
- Manufacturing 10 (40%)
- Chemical 5 (20%)
- Software 3 (12%)
- Automotive 3 (12%)
- Biotechnology 3 (12%)
Stage
- Series A 8 (32%)
- Series B 6 (24%)
- Seed 5 (20%)
- Venture - Series Unknown 2 (8%)
- Series C 1 (4%)
Country
- United States 10 (40%)
- United Kingdom 3 (12%)
- Switzerland 2 (8%)
- Italy 1 (4%)
- Germany 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Matthew Jones
Managing Director
|
Managing Director | Total investments: 2 | Find email | |
Peter Vanlaeke
Partner
|
Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sepion Technologies
|
Sepion is an advanced membrane company offering a platform suite of highly-tunable nanoscale membranes for multiple industrial markets. The company was founded in 2015 and is based in Emeryville, California, United States. | $10M / Series B / Mar 26, 2026 | |
DePoly
|
DePoly is a chemical recycling company that converts post-consumer PET plastic and polyester textiles back into their main raw components at room temperature, without the need to pre-wash, pre-sort, or separate out other plastics. The raw material can then be sold back to the industry so that new virgin-quality plastic items can be made, creating atruly circular plastic economy. | $23M / Seed / Apr 29, 2025 | |
Tretau
|
TAU brings unparalleled performance, sustainability and reliability to the core of each electric motor. Focused on applications for e-mobility, automotive, energy and agriculture, TAU makes coatings more durable, resistant and light, optimizes underlying production processes for environmental friendliness, pairs artificial intelligence withpeace-of-mind operating simplicity and incubates technologies in electrification and smart sensors. | $1.6M / Series B / Oct 30, 2024 | |
Invizius
|
Invizius offers extra-corporeal treatments for patients that includes dialysis, cardiopulmonary bypass, and ECMO involve the circulation of the patient's blood supply through a machine. Invizius develops H-Guard, an advanced hemocompatible coating capable of preventing foreign body reactions in the blood at the source. Invizius aims torevolutionize dialysis and other extracorporeal treatments. | $1.3M / Venture - Series Unknown / Sep 23, 2024 | |
iCOMAT
|
iCOMAT has pioneered the revolutionary Rapid Tow Shearing (RTS) technology, the first ever defect-free fibre-steering process for composites. This game-changing solution has helped customers unlock new levels of performance from composites, enabling them to manufacture lighter, more cost-effective products that perform better than ever before.Originally a spin-out company from the University of Bristol, iCOMAT has developed a patented manufacturing process for advanced carbon fibre composites which are lighter, stronger & more cost-effective than the state-of-the-art processes for the aerospace, automotive & marine sectors. iCOMAT’s innovative technology, Rapid Tow Shearing (RTS), is the world’s first automated composites manufacturing process that can place carbon fibre tapes along curved paths without generating defects. Its defect-free fibre steering capability realises ultra lightweight composite structures beyond the limit of the conventional straight fibre designs & complex geometry which is not manufacturable using current automated manufacturing technologies. Unique in the world of automated composite manufacturing, iCOMAT’s technology is set to revolutionise transport, driving performance & cost-benefits across multiple markets such as aerospace & automotive. Beyond state-of-the-art lightweighting solutions - Composite materials are anisotropic, they are only strong in the direction of their fibres. iCOMAT’s specialist technology steers the path of fibres, enabling optimisation of mechanical properties at any point of the structure & ultimately improve all aspects of structural performance. This produces lighter, more efficient components & uses material only where needed in the most efficient way so use of raw materials & overall production costs are drastically reduced. World-Class Composite Manufacturing Systems – iCOMAT is proud to be a market-leading solutions provider, working with customers to elevate product performance to the next-level. | $22.5M / Series A / Jun 05, 2024 | |
Bioeutectics
|
Bioeutectics is making industrial products and processes more environmentally friendly by supplying high-performance, natural, and long-lasting solvents. Bioeutectics mimics the way plants create their own solvents utilizing 100% renewable resources using eutectic technology. The company replaces petrochemical solvents used in industrial processesthat have previously been used. By producing green eutectic solvents, they controlled the market with natural alternatives. | $2.1M / Seed / Jan 22, 2024 | |
|
Bioeutectics
|
Bioeutectics is making industrial products and processes more environmentally friendly by supplying high-performance, natural, and long-lasting solvents. Bioeutectics mimics the way plants create their own solvents utilizing 100% renewable resources using eutectic technology. The company replaces petrochemical solvents used in industrial processesthat have previously been used. By producing green eutectic solvents, they controlled the market with natural alternatives. | $2.1M / Seed / Jan 22, 2024 | |
Ardent Process Technologies
|
Compact Membrane Systems specializes in providing scalable membrane solutions for the decarbonization revolution. It develops technology to capture and reduce greenhouse gas emissions, avert global warming, and transform the industry into a long-term sustainable enterprise. | $16.5M / Series A / Aug 02, 2023 | |
Zeda
|
PrinterPrezz is driven by a mission to bring more ideas for innovative medical devices to market faster, connecting medicine and manufacturing to become the first Medifacturing™ company in the world. By developing advanced medical devices using processes that combine expertise in 3D printing, orthopedics, and semiconductor technology. | $16M / Debt Financing / Mar 07, 2023 | |
|
Zeda
|
PrinterPrezz is driven by a mission to bring more ideas for innovative medical devices to market faster, connecting medicine and manufacturing to become the first Medifacturing™ company in the world. By developing advanced medical devices using processes that combine expertise in 3D printing, orthopedics, and semiconductor technology. | $52M / Series B / Mar 07, 2023 | |
| See all 25 investments → | |||
Co-Investors
Boutique Venture Partners
5 deals together
DOV Management
4 deals together
Berkeley Catalyst Fund (BCF)
3 deals together
Founderful
3 deals together
Atento Capital
2 deals together
Calculus Capital
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Syensqo Ventures invest in?
Syensqo Ventures invests primarily in Manufacturing, Chemical and Software startups, most often at Series A and Series B stage. Most of the 25 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Syensqo Ventures's check size?
Syensqo Ventures typically joins rounds of $2.1M–$23M at Seed, $6M–$28M at Series A and $1.6M–$52M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Syensqo Ventures participates in.
How do I contact Syensqo Ventures?
Public channels for Syensqo Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Syensqo Ventures?
The team at Syensqo Ventures includes Matthew Jones (Managing Director) and Peter Vanlaeke (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
